Form D · Biotechnology
GREFFEX INC
Aurora, CO · CIK 0001439539
Offering snapshot reported Aug 11, 2017 · SEC filing
- Reported sold
- $155K Offering amount: $20M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jul 28, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2017 | Initial | $155,000 | No comparison | 2 | SEC filing |
| Jul 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-292663
Source: Form D, filed Aug 11, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jehan Al Meer | Director |
| Sir Walter Bodmer | Director |
| William S. Connolly | Director, Executive |
| John R. Price | Director, Executive |
| Uwe D. Staerz | Director, Executive |
| Phillip Zobrist | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12635 E. Montview Blvd., Suite 308
Aurora, CO, 80045
Aurora, CO, 80045